CL
Climb Bio, Inc. (CLYM) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$11.16
+8.75%
Mkt Cap $509.46M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | — | — | — | -$0.20 | -$0.26 | -30.00% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.16 | -$0.19 | -18.75% |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.19 | -$0.13 | +31.58% |
| Q2 2025 May 14, 2025 | — | — | — | -$0.15 | -$0.31 | -106.67% |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.15 | -$0.13 | +13.33% |
| Q4 2024 Nov 12, 2024 | — | — | — | — | -$0.13 | — |
| Q3 2024 Aug 14, 2024 | — | — | — | — | -$1.81 | — |
| Q2 2024 May 15, 2024 | — | — | — | — | -$0.06 | — |
| Q4 2023 Dec 31, 2023 | — | — | — | -$0.13 | -$0.13 | -2.55% |
| Q3 2023 Sep 30, 2023 | — | — | — | -$0.14 | -$0.15 | -4.70% |
| Q2 2023 Jun 30, 2023 | — | — | — | -$0.16 | -$0.19 | -21.55% |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.25 | -$0.84 | -236.00% |
| Q4 2022 Dec 31, 2022 | — | — | — | -$0.38 | -$0.29 | +22.55% |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.37 | — |
| Q2 2022 Jun 30, 2022 | — | — | — | -$0.43 | -$0.56 | -28.34% |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.50 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.40 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.62 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.37 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$1.60 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.44 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.19 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.14 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.16 | — |